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Single-case experimental designs for behavioral neuroscience
Paul L. Soto, Ph.D.
Department of Psychology, Louisiana State University
Single-case experimental designs (SCEDs) are commonly used in behavior analytic research but rarely
used in behavioral neuroscience research. The recent development of technologies that allow control
of the timing of neurobiological events such as gene expression and neuronal firing enable the fruitful
application of SCEDs for the study of brain–behavior relations. There are at least 3 benefits expected
from applying SCEDs to study how neurobiological events affect behavior. First, SCEDs entail direct
within- and across-subject assessments of reliability, likely increasing the probability of replication across
studies and encouraging a search for the causes of replication failure when they occur. Second, SCEDs
focus on behavior in individual organisms producing a body of knowledge that applies to individuals
rather than population parameters. Finally, SCEDs require fewer animals, decreasing costs and effort
and addressing the ethical obligation to reduce the number of animals used for research. Examples are
provided using hypothetical data generated based on published research. Collaborations between
behavior analysts and behavioral neuroscientists will bring the world within the skin under direct experi-
mental control and broaden our understanding of the determinants of behavior.
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In behavioral research, single-case experi-
mental designs (SCEDs) refer to a family of
research designs in which the focus of analysis
is the individual animal or human participant
(Iversen, 2013; Perone & Hursh, 2013). SCEDs
involve repeated measurements of behavior
before, during, and after an experimental
manipulation to evaluate the manipulation’s
behavioral effect. SCEDs have long been used
in behavioral research (Iversen, 2013) and
were utilized by B. F. Skinner for the study of
operant behavior (Skinner, 1938). SCEDs cur-
rently are used in basic experimental and
applied research in the field of behavior analy-
sis. The value of SCEDs is increasingly recog-
nized in areas outside of behavior analysis
such as medicine (Gabler et al., 2011), rehabil-
itation (Krasny-Pacini & Evans, 2018; Lobo
et al., 2017), clinical psychology (Sexton-
Radek, 2014), health psychology (Dallery
et al., 2013; Kwasnicka et al., 2019), and psy-
chiatry (Marwick et al., 2018).
Although heavily used in behavior analytic
research, SCEDs are rarely used in behavioral
neuroscience research. For example, a
targeted review of articles published in seven
neuroscience journals between 7/31/2019
and 8/31/2020 was conducted that focused
on studies that used both an operant proce-
dure as well as neuroscience techniques suit-
able for use of within-subject experimental
designs (e.g., optogenetics and chemogenetics;
see supplemental material for search details).
For studies involving optogenetics, the search
found that although 83% (20/39) of the arti-
cles involved a within-subject manipulation of
optogenetic stimulation or inhibition, only
35% (7/20) of those articles reported
repeated observations that would allow an
assessment of reliability of the effect of the
manipulation. Further, of those articles that
did report repeated observations, only 43%
(3/7) reported at least three data points
within an experimental condition, which is
considered the minimum required
(Kratochwill et al., 2010). Finally, only 5% (1/
20) of the studies that involved a within-subject
manipulation of optogenetic stimulation or
inhibition reported results from repeated con-
ditions or reversals (defined as implementa-
tion of an experimental manipulation for a
period of time or for a specific response
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followed by a change [e.g., removal of the
manipulation or application of the manipula-
tion to a different response] for a period of
time followed by a return to the original con-
dition). Similarly, of the studies identified that
reported results of chemogenetic manipula-
tions on operant behavior, only 50% (4/8)
used a within-subject chemogenetic manipula-
tion and of those that did, 0% reported
repeated observation or repeated condition
data. Thus, it seems clear that SCEDs are
underutilized in neuroscience research and
when studies do utilize within-subject manipula-
tions, the methodological details do not meet
minimal standards for establishing confidence
in the effect of the independent variable (see
Kratochwill et al., 2010). Despite the infre-
quent use of SCED studies in neuroscience,
the relatively recent development of technolo-
gies that allow control over the timing of
biological events such as gene transcription
and neuronal stimulation or inhibition (e.g.,
optogenetics) enables the use of SCED
methods.
The goal of this manuscript is to encourage
collaborations between behavior analysts and
neuroscientists and to provide some hypotheti-
cal examples of how behavioral studies using
SCEDs could be conducted to address current
topics in behavioral neuroscience. To a large
degree, the content of this paper is an amalgam-
ation of arguments made convincingly by others.
Other authors have elucidated the importance
of rigorous behavioral study as a prerequisite for
the investigation of the necessary and sufficient
neural substrates of behavior (Krakauer
et al., 2017). Other authors have argued con-
vincingly that behavior analysis, with its focus on
observable, measurable behavior in individual
organisms and rigorous methodology, is particu-
larly compatible with behavioral neuroscience
(Donahoe, 2017; Schlinger, 2015). Finally, other
authors have raised concerns about the future
of basic research in behavior analysis
(e.g., Poling, 2010) and have argued that behav-
ior analysis would benefit from collaborations
with neuroscience researchers (e.g., Fox, 2018;
Kangas, 2014; Marr & Zilio, 2013). Building on
those arguments, the focus of this manuscript
will be to argue for the benefits of SCEDs for
behavioral neuroscience research and to suggest
how such studies might be conducted using
hypothetical data generated based on published
behavioral neuroscience research.
Appreciation of the benefits for behavioral
neuroscientists of adopting SCEDs requires an
introduction to SCEDs, their logic, and meth-
odological details. For behavior analytic
readers, the material will be familiar, but for
the non-behavior-analytic reader, the coverage
is necessary. For behavior analytic readers, the
later neuroscience material will be unfamiliar
and thus an introduction to the technologies
is provided.
Potential Barriers to Use of Single-Case
Experimental Designs
Two potential barriers to the adoption of
SCEDs in behavioral neuroscience research
should be addressed prior to further discus-
sion (also see Aeschleman, 1991; Dallery &
Raiff, 2014 for a discussion of these and other
misconceptions). First, one potential barrier to
the use of SCEDs in behavioral neuroscience
research is a misunderstanding that SCEDs fail
to control for confounding variables
(i.e., threats to internal validity; Campbell,
1957). Of most concern in single-case research
are threats to internal validity that derive from
the passage of time or from repeated exposure
to the experimental manipulation because the
designs involve comparing behavior of an indi-
vidual across periods of time in which an
experimental manipulation is repeatedly
administered (Perone & Hursh, 2013). Those
threats include history (something else hap-
pened), maturation (changes in the organism
under study), testing (changes in behavior
due to repeated assessment of the behavior),
and instrumentation (changes in the measure-
ment apparatus). In contrast to group designs
that attempt to control for threats to internal
validity via random assignment of subjects to
control and experimental groups, SCEDs
effectively address these threats by replicating
control and experimental conditions
(Perone & Hursh, 2013; Sidman, 1960). To
the degree that results are demonstrated reli-
ably across replicated conditions, confidence
in the effects of the experimental manipula-
tion on the dependent variable increase
(i.e., the internal validity of the experiment
increases).
A second potential barrier to adoption of
SCEDs in behavioral neuroscience research is
a misunderstanding that SCEDs do not pro-
duce generalizable results (i.e., they fail to
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establish external validity) because they
involve fewer subjects than group designs and
often do not utilize null hypothesis signifi-
cance testing (NHST). As clearly explained
by Branch and Pennypacker (2013), the gen-
erality provided by group designs and NHST
of group design data applies to inferences
about population parameters rather than to
the individual organisms that constitute the
sample or population. The generality provided
by group designs is often mistakenly thought
to apply to individuals and is thus used as an
argument in favor of group designs over
SCEDs.
As described by Branch (2014), there are
two ways in which group designs and the typi-
cal analysis of group designs via NHST may
lead to erroneous conclusions about individ-
uals. First, group means may not be represen-
tative of many or even one subject (e.g., a
marriage rate of 48% in the population does
not apply to any individual in the popula-
tion—no one is 48% married). This can be an
issue when a therapeutic intervention is
implemented for an individual patient based
on group results (Kravitz et al., 2004;
Williams, 2010). Further, when an indepen-
dent variable is manipulated quantitatively
over a range of values for each subject to
determine the relation between the indepen-
dent and dependent variable, it also is the case
that averaging across subjects may yield a rela-
tion that fails to accurately depict the relation
in the individual subjects (see Branch, 2019
for an example from dark adaptation; see
Gallistel et al., 2004 for a discussion of the
issue related to learning curves).
A second, more subtle way in which group
designs may lead to erroneous conclusions
about individuals may arise when different
groups are used to evaluate the effects of each
value of a quantitatively varied independent
variable. In such a circumstance, the resulting
relation between the independent and depen-
dent variables may not be representative of
the relation for the individuals. This is because
no individual can experience every level of the
independent variable without having experi-
enced one or more levels of the independent
variable previously (i.e., experience every level
of the independent variable without any his-
tory of prior exposure to the independent vari-
able). For example, if prior drug exposure
affects subsequent response to a drug, the
dose-effect curve obtained using separate
groups of animals for each dose and the dose-
effect curves obtained via repeated dosing in
individual animals likely would differ (see
Branch, 2019; Branch & Pennypacker, 2013;
Sidman, 1960 for other examples and further
discussion of this issue). For those interested
in phenomena at the individual organism
level, this is not a complication that can be cir-
cumvented by using group designs. Thus,
although group designs may avoid some the
issues related to repeated assessments of a vari-
able’s effects, the results obtained may not cor-
respond with results that would be obtained
with individual subjects.
In summary, SCEDs produce generalizable
results in the most direct manner possible, via
systematic replication, establishing whether
previously observed effects of an experimental
manipulation apply across conditions different
from those of the original experiment
(Sidman, 1960). Importantly, SCED findings
systematically replicated across studies estab-
lish the external validity of the findings and
apply to individuals rather than groups of indi-
viduals (Branch & Pennypacker, 2013). That
is, the more a finding is replicated at the indi-
vidual level across studies that vary in terms of
types of participants/subjects, settings, and
other features, the greater the generality of
the finding at the individual participant/sub-
ject level.
Overview of Single-Case Experimental Designs
The use of SCEDs to study phenomena in
whole, living organisms can be traced back at
least as far as Claude Bernard’s work on physi-
ology and subsequently to Ivan Pavlov’s work
on classical conditioning (Iversen 2013). Thus,
although the use of SCEDs in psychology
today is primarily limited to the experimental
and applied analyses of behavior, their use
extends beyond those areas historically.
Research using SCEDs is based on a philo-
sophical position, supported by a wealth of
data, that the behavior of individual organisms
is orderly and can be the subject of scientific
inquiry. It is, of course, the case that individual
organisms behave, and those behaviors pro-
duce effects on the environment that may sub-
sequently alter the behavior of the organism.
It is the individual that burns her hand when
she touches a hot stove, not the group. It also
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is the case that organisms have nervous sys-
tems whose function underlies behavior and
that those nervous systems are not shared
between organisms. Finally, it also is the indi-
vidual who must be treated when behavior
becomes problematic (e.g., when obsessive–
compulsive behavior interferes with an individ-
ual’s daily functioning). Thus, from a SCED
perspective, behavior is a phenomenon that
occurs in individual organisms and as a result,
can be studied at the individual level.
SCEDs in behavioral research evaluate the
impact of an experimental manipulation on a
behavioral outcome for an individual organism.
Determination of the impact of an experimen-
tal manipulation rests on repeated observations
of the behavior during control and experimen-
tal conditions and comparison of the resulting
series of observations from those conditions.
SCEDs are particularly well-suited to experi-
mental investigations of the determinants of
behavior because behavior is a phenomenon
that applies uniquely to individual organisms.
Similarly, nervous system functioning is a phe-
nomenon that applies uniquely to individual
organisms, and as such SCEDs should be useful
for evaluating the impact of neurobiological
manipulations such as changes in gene expres-
sion and neuronal activity on behavior. It is
important to note that the designs described
below do not encompass all possible single-case
experimental approaches. Designs can be mod-
ified and combined to provide confidence in
the effects of the experimental manipulation.
Types of Designs
Reversal Designs
A single-case reversal design involves
repeated observations of behavior from each
of at least three conditions. The A-B-A reversal
design first implements a baseline condition
(A) during which the manipulation of interest
is not applied, followed by an experimental
condition during which the manipulation of
interest is applied (B), followed by a return to
the baseline condition (A). Importantly,
repeated observations of behavior are
obtained during each condition and imple-
mentation of the experimental condition and
the return to the baseline condition are typi-
cally not conducted until stability of behavior
is achieved in the preceding condition (for a
discussion of issues relating to stability of
behavior see Perone and Hursh 2013). Thus,
in an ideal scenario, a clear change in behav-
ior during the experimental condition
followed by a return of behavior to baseline
levels following a return to the baseline condi-
tion provides a strong argument for the exper-
imental manipulation being the cause of the
behavioral change rather than other variables
(threats to internal validity). For example,
from a behavioral neuroscience perspective, a
SCED could evaluate the impact of a manipu-
lation such as transcription of a gene by com-
paring repeated behavioral observations
during a time period when the gene was being
transcribed (B condition) to repeated behav-
ioral observations during time periods prior to
(initial A condition) and after (second A con-
dition) the period during which the gene was
transcribed.
The A-B-A reversal design can be extended
to include replication of the experimental
intervention. An A-B-A-B reversal design there-
fore entails a baseline condition, followed by an
experimental manipulation condition, followed
by a second baseline condition, followed by a
final experimental manipulation condition. As
with the A-B-A design, each condition is
implemented after behavior reaches stability in
the preceding condition. The question is
whether behavior changes in an orderly fashion
with implementation (observed twice) and
removal (observed once) of the experimental
condition. Of course, variations of reversal
designs are endless and can include any num-
ber of replications of the A and B conditions as
well as other experimental manipulation condi-
tions (e.g., an A-B-C-A-B-C-A reversal design
with a repeated baseline condition labeled A
and two repeated experimental conditions
labeled B and C). Importantly, the degree to
which the pattern of behavior observed during
the first baseline condition and changes in
behavior observed during the first experimen-
tal condition recur during subsequent baseline
and experimental conditions, respectively,
determines the confidence of the researcher
that the experimental manipulation, and not
some alternative confounding variable, is
responsible for the observed behavioral
changes.
Multiple Baseline Designs
Multiple baseline designs offer a single-case
approach to evaluate the behavioral impact of
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an experimental manipulation that cannot be
reversed (e.g., permanent deletion of a gene).
One type of multiple baseline design is the
multiple-baseline design across cases in which
the experimental manipulation is replicated
across individual subjects in a staggered fash-
ion such that each subject is exposed to the
baseline condition for differing lengths of
time. Once behavior is deemed stable for the
first subject, the experimental manipulation is
made for that subject. Importantly, the effect
of the experimental manipulation on behavior
is assessed for the first subject before the
manipulation is implemented for the second
subject and so on. Maintaining the baseline
condition for subsequent subjects while the
experimental manipulation is imposed for a
previous subject allows the researcher to use
the baseline performances of the subsequent
subjects as a control for confounding variables.
In this respect, a multiple baseline design is
unlike the other SCEDs because it involves
comparison across subjects to increase confi-
dence in the effect of the manipulation on the
behavior of an individual subject. If behavior
changes for each subject only after the experi-
mental manipulation and simultaneously does
not change for subjects for whom the manipu-
lation has not been implemented, alternative
explanations become implausible. For exam-
ple, a multiple baseline across cases design
could be used to evaluate the behavioral
impact of a nonreversible neurobiological
manipulation such as gene deletion or knock-
out. Staggering the timing of the gene dele-
tion for different subjects could be used to
determine whether behavior changes after
and only after the gene is deleted for each
subject.
Multielement Design
A multielement design can be used to evalu-
ate the behavioral effect of one or more
experimental manipulations by frequently
changing conditions to assess the impact of
each condition. The effect of the independent
variable on the dependent variable is
established for an individual subject when
there is a clear differentiation in responding
between conditions. For example, application
of a multielement design to evaluate a neuro-
scientific question such as how light stimula-
tion of neurons (optogenetic stimulation)
alters behavior could involve arranging, within
experimental sessions, time periods during
which no manipulation is implemented, time
periods during which neurons are stimulated
(i.e., produces neuronal firing) via light expo-
sure, and possibly time periods during which
neurons are exposed to light of a wavelength
that does not modify neuronal firing (see
Optogenetics section below). If behavior dif-
fers in a systematic fashion across the different
conditions, one’s confidence that behavioral
differences are due to the differences
implemented across conditions is increased.
Importantly, the reliability of the differences
obtained across conditions addresses the inter-
nal validity of conclusions of the independent
variable’s causal impact.
Factorial Design
A factorial design is one in which two or
more experimental variables are manipulated
and the effects of all possible combinations of
the imposed levels of the variables examined.
A single-case experiment factorial design
involves exposing each subject to all combina-
tions of the manipulated variables. Such
designs may be particularly useful in behav-
ioral neuroscientific investigations where the
impact of a brain manipulation may depend
on one or more environmental variables. For
example, the behavioral effect of inducing or
silencing expression of a gene coding for a
neurotransmitter receptor may depend on
parameters such as the value of the schedule
of reinforcement. Threats to internal validity
relating to the passage of time can be
addressed by replication of one or more con-
ditions (i.e., combinations of the variables).
Parametric Design
A parametric design is one in which an
experimental manipulation is varied quantita-
tively over three or typically more values. If
behavior varies in an orderly manner with
changes in the values of the experimental vari-
able, confidence in the causal impact of the
experimental manipulation increases. If condi-
tions are arranged in a strictly ascending or
descending sequence (e.g., increasing or
decreasing values of reinforcer magnitude or
drug dose), threats to internal validity relating
to time (e.g., maturation, testing) can be elimi-
nated by replicating selected conditions
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(Perone & Hursh, 2013). Alternatively, condi-
tions can be arranged in a random-ordered
sequence. Parametric designs can be used in
behavioral neuroscience to assess parametri-
cally the effects of a neurobiological manipula-
tion on behavior in individual organisms. For
example, a parametric design could be used to
assess how optogenetic stimulation or inhibi-
tion of neurons affects demand for a rein-
forcer, assessed across a series of fixed-ratio
(FR) schedules of reinforcement.
General Considerations
One issue that naturally arises in consider-
ation of SCEDs is that of how many observa-
tions are needed within an experimental
condition and how many intra- and intersubject
replications are necessary to produce confi-
dence in the effect of the independent variable.
Unfortunately, there are no definitive answers
because the answers depend on multiple fac-
tors such as the likelihood of the results consid-
ering previously established findings, the
magnitude of the effect, the variability of the
behavior, the time needed for behavior to
reach stability, and the goals of the experi-
menter (see Branch and Pennypacker, 2013,
for a discussion). Although guidelines have
been proposed (e.g., Kratochwill et al., 2010),
ultimately such decisions must be made by the
scientist and must be convincing to their peers.
A related issue is how to approach failures
to replicate, either within or across subjects.
Failures to replicate the effect of an indepen-
dent variable manipulation may lead one to
conclude that previous demonstrations of
effect were anomalies and/or due to chance.
However, as discussed by Perone (2019), if
effects were demonstrated convincingly in
other subjects or in previous conditions, such
a conclusion would be unjustified. Rather, if a
manipulation can be demonstrated to produce
a reliable effect for an individual but does not
yield the same outcomes for another
individual (or in later conditions for the first
individual), what is revealed is a lack of under-
standing and/or control of all relevant vari-
ables. As Perone details, investigations that are
conducted to address these gaps in under-
standing can increase our knowledge of the
relevant variables (see Clark and Steele 1963
for an example of how differences in the
behavioral effects of chlorpromazine between
two rats were resolved by subsequent experi-
mental manipulations).
A third issue for consideration in the use of
SCEDs involves independent variable effects
that are irreversible or long-lasting. Examples
(e.g., math acquisition, language learning,
brain lesions) are numerous. The use of irre-
versible manipulations such as brain lesions in
neuroscience may have contributed to the lack
of use of SCEDs in neuroscience. Further, irre-
versible manipulations that are time-sensitive
(e.g., early-life manipulations that produce
long-lasting permanent changes) are not suit-
able for investigation with SCEDs. As
described above, irreversible manipulations
that can be implemented at different
timepoints for different subjects (multiple
baseline design) can be used to study irrevers-
ible effects in individual subjects. Additionally,
assessing behavioral changes at the individual
subject level when a manipulation produces
long-lasting effects is possible. For example,
when repeated administration of a drug pro-
duces tolerance, a dose-effect curve can be
evaluated before, during, and after chronic
drug treatment to establish changes in drug
effect for each subject (e.g., Marusich &
Branch, 2009; Minervini & Branch, 2013).
Thus, although irreversible and long-lasting
effects represent a challenge for SCEDs, and
in certain cases may necessitate group compar-
isons, the fact that a manipulation produces
irreversible or long-lasting effects does not, by
itself, render the study of that manipulation
out of reach for SCEDs.
Finally, it is important to note that SCED
research traditionally has relied on visual anal-
ysis of data to ascertain effects of experimental
manipulations as opposed to NHST. One rea-
son for this is that NHST focuses on group
comparisons whereas SCEDs focus on within-
and between-subject replications as the thresh-
old for concluding an effect of an indepen-
dent variable. The individual subject focus and
avoidance of NHST may have shielded SCED
research from replication concerns. As docu-
mented in a large body of literature, NHST is
associated with many issues (Branch, 2014),
including a common misunderstanding that
p values indicate the reliability of a research
finding (Cohen, 1994; Falk & Greenbaum,
1995; Haller & Kraus, 2002; Oakes, 1986;
Sohn, 1998). This misunderstanding of p values
has been identified as another factor
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contributing to the “replication crisis” in psy-
chology because the misunderstanding dis-
courages conduct of actual replications
(Branch, 2019; Perone, 2019). Further, misun-
derstandings and misuse of p values in NHST
are so pervasive that a recent editorial in an
issue of the Journal of the American Statistical Asso-
ciation called for an end to use of the phrase
“statistical significance” and the dichotomiza-
tion of results into statistically and not statisti-
cally significant (Wasserstein et al., 2019).
Importantly, statistical methods for the analysis
of SCED data that are not simply focused on
rejection of the null hypothesis are available
(e.g., Parker et al., 2011) and being developed
(see Fisher & Lerman, 2014; Young, 2019).
Additionally, standard statistical significance
approaches can be used to bolster the analysis
of data when needed (e.g., when journals
require p-values for publication). Regardless of
whether a visual, statistical, or combined analy-
sis is undertaken, by focusing on an assessment
of effects at the individual subject level, SCEDs
are not subject to the issues inherent with
NHST and can deliver what some mistakenly
believe NHST provides: a direct assessment of
the within- and between-subject reliability of
the findings.
Benefits for the Use of SCEDs
Researchers in behavioral neuroscience could
benefit from adoption of SCEDs. First, SCEDs
entail direct within- and across-subject assess-
ments of reliability, likely increasing the proba-
bility of replication across studies (Branch,
2019) and encouraging a search for the causes
of replication failure when failures occur
(Perone, 2019). SCEDs assess reliability of
results within an experiment by conducting
repeated measurements within conditions and
by repeating conditions within and across sub-
jects. The importance of replication has long
been recognized (e.g., Cohen, 1994;
Ioannidis, 2013a). In fact, a lack of replication
attempts has been identified as one factor con-
tributing to the “replication crisis” in psychology
and other areas of science (Ioannidis, 2013a,
2013b; Lilienfeld, 2017; cf. Open Science
Collaboration, 2015; Pashler & Harris, 2012). As
noted by Branch (2019), it is hard to imagine
how experiments that involve within- and
between-subject assessments of reliability could
generate findings with lower likelihood of repli-
cation than is currently estimated in psychology.
A second benefit of SCEDS for behavioral
neuroscientists is that use of SCEDs generates a
body of knowledge regarding processes that
apply to the individual organism rather than a
population parameter (Branch, 2014; Branch &
Pennypacker, 2013; Sidman, 1960). As
described above, behavior is properly construed
as a phenomenon that occurs at the individual
organism level and thus a science of behavior
should generate knowledge that applies at the
individual organism level. This is contrasted
with the results obtained from group designs,
which may apply to the population from which
the samples used were drawn, but do not typi-
cally permit inferences to be made about indi-
viduals comprising the samples.
Finally, SCEDs require fewer animals which
decreases costs and effort and addresses the
ethical obligation to reduce the number of
nonhuman animals used for research. These
benefits derive from the fact that, by using
each animal as its own control, SCEDs can
reduce the number of animals required to
convincingly demonstrate an experimental
effect. As a practical matter, a reduction in the
number of animals translates to a reduction in
research costs and labor. A reduction in the
number of animals may be of particular bene-
fit in behavioral neuroscience for two reasons.
First, many of the techniques are procedurally
involved (e.g., stereotaxic surgery). Second, by
providing an avenue to reduce the number of
animals used, a SCED approach provides a via-
ble alternative to calls to greatly increase sam-
ple sizes (e.g., sample sizes in the hundreds of
animals) to address low power in group design
studies (Button et al., 2013). Although the
focus of this paper is on research with non-
human animals, it may be of interest that
others have called for greatly increased sample
sizes to address low power in group design
studies with humans (Turner et al., 2018).
Thus, the arguments made here suggest equiv-
alent benefits with respect to human research.
As an ethical matter, a reduction in the
number of animals addresses the ethical
objective to use the minimum number of non-
human animals necessary to obtain informa-
tion, one of the three “Rs” (reduce, refine,
replace) of ethical research with nonhuman
animals (Russell & Burch, 1959).
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Technologies for Behavioral Neuroscience
Technologies are available that enable con-
trol over neurobiological processes such as
gene expression in neurons and the activity of
neurons in brain-region and neuron type-spe-
cific, manners. Critically, available technolo-
gies enable control over the timing of such
manipulations, and it is therefore possible to
investigate brain–behavior relations using
SCEDs. A brief discussion of each of these
technologies follows, along with examples
from the literature of the use of these technol-
ogies to address behavioral questions. Each
example from the literature is considered
from the standpoint of how a SCED could be
used to evaluate the effect of the employed
manipulations on behavior.
In the examples detailed below, the investi-
gations of the behavioral effects of neurobio-
logical variables can be viewed as bridging the
fields of neuroscience and behavior analysis by
evaluating the neural substrates and processes
that mediate and/or modulate the behavioral
functions of environmental stimuli. Another
approach, and possibly one of more interest to
behavior analysts, is to investigate neurobiolog-
ical variables as stimuli with reinforcing,
punishing, and discriminative functions or as
motivating operations that alter the rein-
forcing or punishing effectiveness of other
stimuli (cf. Ortu & Vaidya, 2017; Thompson,
2007). Although some examples of this
approach exist, they are far fewer than
approaches to identifying substrates that medi-
ate and/or modulate behavioral phenomena.
Suggestions for future research on the role of
neurobiological variables as variables with stim-
ulus functions or motivating effects are
suggested in the conclusion of this paper.
Technologies for Controlling Gene
Expression
Two approaches to control gene expression
are to (1) control gene expression via delivery of
an exogenous agent to animals genetically
engineered such that transcription of a target
gene depends on the presence or absence of the
exogenous agent (Das et al., 2016) and
(2) deliver genetic material into an organism via
a viral vector such as adeno-associated virus
(AAV; Naso et al., 2017). Often technologies are
combined to achieve precise control over timing
and spatial location of a manipulation
(e.g., injection of a viral vector containing a gene
of interest into a genetically engineered animal
that ultimately results in expression of the target
gene only in neurons of a specific type).
Tetracycline-Inducible Systems for Modifying Gene
Expression
The tetracycline-controlled Tet-Off and Tet-
On systems are used to turn gene expression
on or off via the presence or absence of tetra-
cycline or tetracycline derivatives like doxycy-
cline (for a review see Das et al., 2016;
Gossen & Bujard, 1992, 1995). The Tet-On sys-
tem, for example, allows expression of a target
gene in the presence of doxycycline (tetracy-
cline is less effective in the Tet-On system). In
contrast, the Tet-Off system activates expres-
sion of a gene in the absence of tetracycline or
its derivatives, thus allowing gene expression
to be terminated by administration of tetracy-
cline or tetracycline-derivatives (Das et al.
2016). Thus, with both the Tet-Off and Tet-
On systems, it is possible to control gene
expression by administration of tetracycline or
doxycycline.
Ward et al. (2012) used the Tet-Off system
to control expression of the gene for the
human long form of the dopamine (DA) D2
receptor (D2R) in transgenic mice containing
the gene in their genome. Because they used
the Tet-Off system, the human DA D2R gene
was expressed in the absence and not
expressed in the presence of doxycycline.
Ward et al. referred to the transgenic mice
expressing the human long form of the DA
D2R as D2R-overexpressing mice because the
mice expressed both native D2Rs and human
D2Rs. Ward et al. evaluated multiple behav-
ioral measures in control mice and D2R-
overexpressing mice, but for the purpose of
this discussion only one of their behavioral
assessments is reported here. Ward et al. evalu-
ated responding of mice in an “effort-related
choice paradigm” (Salamone et al., 1991) in
which mice responded under random ratio
(RR) 5, 10, and 20 schedules of evaporated
milk delivery (several sessions at each RR
value) in the presence of freely available
home-cage chow. In control mice and DA
D2R-overexpressing mice, the average number
of lever presses emitted increased as the ratio
value increased, but the increases were smaller
in the DA D2R-overexpressing mice. In a
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separate group of DA D2R-overexpressing
mice fed a diet containing doxycycline, which
turned off transcription of the human DA
D2R gene, the average number of responses
emitted at each RR schedule value was very
similar to the number of responses in the
control mice.
An alternative approach to assess the role of
DA D2Rs in RR responding would be to use a
combined factorial/reversal design for each
animal. The beauty of the tetracycline-
inducible system is the ability to control gene
transcription via administration of tetracy-
cline/doxycycline in a reversible manner.
Thus, one group of mice containing the trans-
gene could be used in a combined factorial/
reversal design in which RR responding was
evaluated repeatedly during periods of time
with the gene turned on and off. An efficient
approach to evaluating the effect of transgene
transcription on responding under several RR
schedules of reinforcement would be to
arrange a three-component multiple schedule
of reinforcement composed of the three RR
values. A multiple schedule is one in which
two or more schedules with distinct correlated
stimuli alternate within session, which allows
measurement of responding across multiple
schedules in the same session. Repeated rever-
sals would increase confidence in any observed
changes in RR responding (in the presence of
home cage chow), during periods when the
transgene was being expressed versus when it
was not being expressed.
For visualization, hypothetical results pro-
ducing similar average results to those
obtained by Ward et al. (2012) are shown in
Figure 1 for three subjects. For each hypotheti-
cal subject, responding is evaluated first in the
absence of doxycycline (Gene On; data points
to the left of the first vertical line) and next in
the presence of doxycycline (Gene Off; data
points between the first and second vertical
lines), followed by repeated assessments of
each (technically, a combined factorial ABAB
design). An important consideration when
using inducible gene expression is the dura-
tion of time required for gene expression or
silencing, which might depend on the gene
and target tissue. If those details are known,
one approach would be to suspend experi-
mental sessions for the necessary duration of
time following addition or removal of doxycy-
cline which, for simplicity, is the assumption
for the data presentation in Figure 1. An alter-
native approach would be to continue experi-
mental sessions following addition or removal
of doxycycline to directly assess changes in
behavior with changes in expression levels of
the regulated gene. Such an approach might
be particularly useful if the duration of time
required for establishing or terminating gene
expression is not known.
Based on the results of Ward et al. (2012),
we would expect increases in responding in
the larger RR schedules during the Gene Off
compared to Gene On phases. Results like
those shown in Figure 1 would provide com-
pelling evidence of the causal effects of
human long form DA D2R expression on RR
responding reinforced by evaporated milk
delivery in the presence of chow. The benefit
of such an approach over the group compari-
son approach would be an assessment of the
reliability of the effects within and across ani-
mals and a substantial reduction in the num-
ber of animals used (e.g., from four groups of
seven to eight mice in the Ward et al. study to
one group of mice).
Viral Vector Delivery of Genes
Trifilieff et al. (2013) injected a viral vector
containing the gene for the human long form
of the DA D2R along with the gene for pro-
ducing green fluorescence protein (GFP; a
protein called a “reporter” used to visualize
viral vector transfection of targeted cells) into
the nucleus accumbens of mice. Trifilieff et al.
reported increased responding on a progres-
sive ratio (PR) schedule of evaporated milk
reinforcement in mice overexpressing DA
D2Rs in the nucleus accumbens compared to
mice injected with a viral vector carrying
just GFP.
In the Trifilieff et al. (2013) study, over-
expression of DA D2Rs was not under revers-
ible control. Once the target gene was
introduced via viral vector injection, it was not
possible to turn off transgene expression.
Because the manipulation could not be
reversed, a SCED investigation of the behav-
ioral effects of introducing the gene would
require the use of a multiple baseline design.
For example, mice could be trained to
respond on a PR schedule of evaporated milk
reinforcement. Following an appropriate base-
line period of responding in which stability of
responding was achieved, the viral vector
455Single-Case Experimental Designs Neuroscience
carrying the target gene could be injected at
different time points in different animals to
assess the effect of gene transcription
(i.e., receptor expression) on behavior.
The experimental scenario is illustrated in
Figure 2 using hypothetical data generated
based on the PR results of Trifilieff
et al. (2013). For each animal, PR responding
Figure 1
Hypothetical Total Responses as a Function of Session, RR value, and Gene Expression Status in a Reversal Design
Note. Data were generated assuming that each phase was conducted after an appropriate time following addition or
removal of doxycycline to allow for gene expression or its prevention to occur. An alternative approach would be to con-
tinue sessions without any break following addition or removal of doxycycline to track the time of onset of effects from
the point at which doxycycline was added or removed from the diet. Inset graphs display average responses at each RR
value for the last 3 sessions of each phase (for comparison see Figure 4 of Ward et al. 2012). Data points in inset graphs
are jittered to prevent overlapping of data points.
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first is assessed prior to viral vector injection
(Fig. 2, Baseline). Next, PR responding is
assessed following injection of a viral vector
containing the D2R transgene (and reporter)
(Fig. 2, AAV-D2R). To the degree that
responding changes only after injection of the
viral vector in each animal and injection time
points are appropriately staggered to allow
comparison of baseline responding in subse-
quent subjects following behavioral changes in
prior subjects, the behavioral changes can be
reasonably attributed to the injection. As with
the tetracycline-inducible systems described
above, an important factor is the time
required for gene expression to occur. For
simplicity, the assumption made in Figure 2 is
that those details are known, and experimen-
tal sessions are suspended for the necessary
duration of time. An alternative would be to
continue experimental sessions after an appro-
priate postsurgery recovery period and directly
assess the onset of effects.
One concern of using a multiple baseline
design to assess the effects of viral vector deliv-
ery of a transgene would be the lack of control
for any possible effects of the viral vector itself.
To address such possible effects, one could
use another group of subjects that receive the
viral vector with a reporter but without the
transgene in a multiple baseline design. If the
subjects receiving the viral vector containing a
reporter fail to exhibit behavioral changes
while those receiving a viral vector containing
the transgene (and reporter) do exhibit
behavioral changes, confidence that the
behavioral changes in the latter group are due
to the transgene would be increased. Thus, in
this example, the resulting design would retain
a focus on the behavior of the individual sub-
jects while simultaneously employing group-
level comparisons.
Technologies for Controlling Neuronal
Activity
Multiple technologies have been developed
that allow control over neuronal activity. One
technology is optogenetics, in which neurons
are genetically engineered to express light-
sensitive ion channels that when opened pro-
duce inhibitory or excitatory effects on the
neuron (Boyden et al., 2005; for a review see
Deisseroth, 2011). Another technology for
controlling neuronal activity is chemogenetics,
in which neurons are genetically engineered
to express specialized receptors that are only
sensitive to an otherwise putatively inactive
ligand. The specialized receptors and the tech-
nology are often referred to as designer recep-
tors exclusively activated by designer drugs
(DREADDs) (Armbruster et al., 2007).
Optogenetics
Optogenetics is a technology that utilizes
genetic engineering to express light-sensitive
proteins called opsins in cells (for reviews see
Deisseroth, 2011; Guru et al., 2015). Once
expressed in the membrane of a neuron,
opsins can be stimulated by specific light wave-
lengths. Ion channel opsins are available that,
when opened in response to light, allow influx
of positively charged ions that depolarize the
neuron and increase the frequency of action
potentials. Ion channel opsins also are avail-
able that allow influx of negatively charged
ions that, when opened in response to light,
hyperpolarize the neuron and decrease the
frequency of action potentials. Thus, stimula-
tion and inhibition of neurons can be con-
trolled by exposure to light of a specific
wavelength. Light exposure is controlled by a
laser fiber implanted into the target region.
Roltsch Hellard et al. (2019) utilized
optogenetic stimulation to investigate the
involvement of the dorsal medial striatum
(DMS) in ethanol self-administration and rein-
statement following extinction. For this illus-
tration, only the effects of optogenetic
stimulation on ethanol self-administration are
discussed. Roltsch Hellard et al. specifically
were interested in DMS neurons that projec-
ted to another area called the substantia nigra.
The methods used to specifically target only
DMS neurons with projections to the sub-
stantia nigra were complex and require some
detailed explanation. To selectively target only
those DMS neurons with projections to the
substantia nigra, Roltsch Hellard et al. used
two viral vector injections: one injection into
the DMS and one into the substantia nigra.
The first injection, into the DMS, contained
the gene for halorhodopsin, an ion channel
receptor that, when opened, allows influx of
negatively charged chloride ions, producing
hyperpolarization and decreased firing of the
affected neuron. The halorhodopsin gene
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delivered by the viral vector was Cre-depen-
dent, which means that the gene is only
expressed in the presence of an enzyme called
Cre (for reviews see Mortensen, 2006;
Sauer, 1998). Thus, the halorhodopsin gene
was delivered to DMS neurons, but could not
be expressed unless the Cre enzyme was pre-
sent. The second injection, into the substantia
nigra, contained the gene for the Cre enzyme.
Importantly, the virus injected into the sub-
stantia nigra was a retrograde virus. A retro-
grade virus is one that will travel up the axons
of neurons that it enters to reach the cell body
of the neuron. Thus, the virus was expected to
enter axon terminals in the substantia nigra,
travel up the axons to reach the neuron cell
bodies from which the axon terminals origi-
nated, and deliver the Cre DNA to those neu-
ron cell bodies. Thus, by using these two
injections, the Cre-dependent halorhodopsin
channels should only have been expressed in
the cell bodies of DMS neurons that project to
the substantia nigra, because only those cell
bodies would contain both Cre and Cre-
dependent halorhodopsin (note that other
neurons would have one or the other, but
not both).
In the Roltsch Hellard et al. (2019) study,
prior to viral injection, rats were trained to
lever press using response-contingent delivery
of 20% ethanol (v/v). Following ethanol self-
administration training, rats underwent viral
injection as described above and following
recovery from surgery, the effects of inhibiting
DMS neurons, produced by exposure to a yel-
low light, on ethanol self-administration were
evaluated. Relative to a session occurring prior
to surgery (“Baseline”) and a session (“Light
Off”) 48 hr after a session during which the
yellow light was on, lever-pressing reinforced
by presentation of ethanol was suppressed by
yellow light illumination in the DMS.
In the Roltsch Hellard et al. (2019) study,
the effect of inhibiting substantia nigra-
projecting DMS neurons on ethanol self-
administration was assessed by comparing
responding during a single baseline session, a
single light on session, and a single subsequent
session with the light off (48 hr post light stim-
ulation). Although each rat was exposed to all
three conditions, individual rat data were not
presented nor were multiple sessions con-
ducted with light on or off. Thus, reliability at
the individual subject level cannot be assessed.
However, the effects of light activation of the
halorhodopsin channel receptor, a reversible
manipulation, could be evaluated using a
single-subject reversal design. Repeated ses-
sions with and without light activation of the
receptor would be useful to determine the
reliability of the effect in individual rats. Fur-
ther, the effects of a putatively “nonfunctional”
light (i.e., light of a wavelength that should
not activate the halorhodopsin channel recep-
tors) also could be evaluated to control for the
effects of light, per se.
Because the time precision of optogenetic
stimulation is so high, a useful design to
Figure 2
Hypothetical Total Progressive Ratio Responses as a Function of
Session and Phase in a Multiple Baseline Design
Note. The dotted vertical line indicates the time at which
the AAV containing the D2R gene was injected. White
data points for Subject 2 and 3 indicate results obtained
when Subject 1 was administered the AAV containing the
D2R gene. Dark gray data points for Subject 3 indicate
results obtained when Subject 2 was administered the AAV
containing the D2R. For comparison see Figure 3A from
Trifilieff et al. (2013).
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evaluate its behavioral effects would be a mul-
tielement design in which sessions alternated
between light stimulation, no light stimulation,
and nonfunctional light exposure. Figure 3 illus-
trates some hypothetical data that might be
expected, based on the Roltsch Hellard
et al. (2019) results, from a multielement design
in which sessions varied from day to day between
Yellow Light (the wavelength that activates
halorhodopsin), No Light, and Other Light
manipulations in a single subject. Clear separa-
tion of rates of lever pressing would convincingly
demonstrate the causal impact of light illumina-
tion of halorhodopsin-expressing neurons on
ethanol self-administration. Replication of simi-
lar outcomes with additional subjects would bol-
ster the intersubject reliability of the effect.
Finally, selectivity of the effects could be exam-
ined by evaluating the effects of halorhodopsin
stimulation on responding reinforced by other
consequences (e.g., sucrose presentation).
Chemogenetics
Chemogenetics is a technology that utilizes
genetic engineering to produce cellular
expression of receptors that can be activated
by administration of an otherwise putatively
inactive molecule such as clozapine-N-oxide
(CNO) (for a review see Roth, 2016). A variety
of receptor types have been developed based
on modification of human muscarinic (G-
protein coupled) receptors. When bound by
CNO, the modified human muscarinic recep-
tors produce G-protein-mediated excitatory or
inhibitory effects on the receptor-expressing
neuron, depending on the specific type of
receptor expressed. The receptors are often
referred to as Designer Receptors Exclusively
Activated by Designer Drugs (DREADDs).
Expression of the desired receptor in neurons
can be achieved via injection of a viral vector
containing the gene for the target receptor.
Subsequently, CNO can be administered via
standard routes (e.g., in food and via intraperi-
toneal injection). Interestingly, transgenic
mice with Cre-dependent DREADD are
emerging (e.g., Akhmedov et al., 2017; Farrell
et al., 2013; Zhu et al., 2016). Cre-dependent
DREADD mice contain the gene for a
designer receptor but require the presence of
the Cre enzyme for expression of the designer
receptor. Expression of the designer receptor
in target neurons can be achieved by crossing
Cre-dependent DREADD mice with mice
expressing Cre in the target neurons (Cre
mice are readily available from several ven-
dors), which eliminates the need for surgery
to inject a viral vector containing the
receptor gene.
Warthen et al. (2016) investigated the role
of medial prefrontal cortex (mPFC) pyramidal
neurons in mediating behavior maintained by
food reinforcement using a range of behav-
ioral procedures. Warthen et al. used viral vec-
tor injection to deliver the gene for modified
human muscarinic 3 (hM3Dq) receptors
(G protein-coupled excitatory receptors) into
the mPFC of mice. In one portion of the
study, Warthen et al. trained mice to emit nose
poke responses using food reinforcement. Ini-
tially, responses in a center nose poke hole
produced food pellet delivery under an FR
1 schedule of reinforcement and in subse-
quent sessions under FR 3 and FR 5 schedules
of reinforcement. Next, mice were exposed to
two sessions of a PR schedule of food delivery,
with one session preceded by injection of
0.5 mg/kg CNO and the other preceded by
injection of saline (order counterbalanced
across mice). CNO administration increased
breakpoint, total nose poke responses, and
reinforcers obtained relative to saline when
mice were food-restricted but not when mice
were fed ad lib. Although each mouse was
administered CNO and saline, single mouse
data were not presented nor were multiple ses-
sions conducted with CNO or saline adminis-
tration. Thus, reliability at the individual
subject level cannot be assessed. Given the
Figure 3
Hypothetical Response Rates as a Function of Session and Laser
Status Using a Multielement Design
Note. For comparison see Figure 2D of Roltsch-Hellard
et al. (2019).
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reversible nature of CNO administration, the
effects of CNO and saline administration could
be evaluated repeatedly to assess the reliability of
the effects of CNO administration on food-
reinforced PR responding. Replication of similar
outcomes with additional subjects would bolster
the intersubject reliability of the effect.
A SCED approach to evaluate the impact of
CNO administration on PR responding in
mice expressing hM3Dq receptors in the
mPFC could be conducted using a design with
reversal phases and probe sessions to assess
effects of CNO and vehicle injection
(a complex design that does not fit neatly into
one of the described designs). First, mice
could be trained to respond under the PR
schedule of food reinforcement with repeated
observations of the breakpoint (Pre-AAV Injec-
tion Baseline; Fig. 4). Once stability of daily
breakpoint values was achieved, the effect of
vehicle and different doses of CNO could be
evaluated using occasional “probe” sessions
(Pre-AAV injection CNO; Fig. 4). After evaluat-
ing the effects of vehicle and CNO administra-
tion on PR breakpoint, the viral vector
containing the gene for hM3Dq receptors
could be injected into the mPFC, and follow-
ing an appropriate surgery recovery time, PR
sessions reinitiated to evaluate the potential
impact of the injection of the viral vector
expressing hM3Dq receptors (Post-AAV Injec-
tion Baseline; Fig. 4). Following achievement
of stability in daily PR breakpoint values, a sec-
ond round of probe sessions could be con-
ducted to evaluate the impact of CNO
administration on breakpoints (Post-AAV
Injection CNO; Fig. 4).
The benefits of the approach detailed in
Figure 4 would be the direct assessment of the
reliability of effects of CNO administration
within a single subject (note that behaviorally
active doses of CNO could be readministered
occasionally to ascertain the reliability of those
effects). Importantly, as with any drug, the
timing of repeated drug injections must be
carefully considered in light of known pharma-
cokinetic and pharmacodynamic actions to
avoid carryover effects from one administra-
tion to another. As described above, to the
degree that carryover effects occur, they must
be addressed directly in SCED research rather
than avoided through the use of group designs.
Further, due to concerns about back metabolism
of CNO to clozapine (Gomez et al., 2017; Ilg
et al., 2018; MacLaren et al., 2016; Manvich
et al., 2018), effects of CNO that occurred after
but not before AAV injection could be more con-
fidently attributed to activation of the hM3Dq
receptors as opposed to off-target actions of
clozapine. Finally, there is continued develop-
ment of ligands with promise of selective acti-
vation of designer receptors without concerns
about back metabolism to an active molecule
or other resulting off-target effects (Bonaventura
et al., 2019).
Mahler et al. (2019) investigated the role of
DA neurons in the ventral tegmental area
(VTA) in behavioral economic demand for
cocaine self-administration. Mahler et al. used
rats expressing Cre-dependent hM3Dq (excit-
atory), rM3Ds (excitatory), or hM4Di (inhibi-
tory) receptors in VTA DA neurons. Cre-
dependent modified receptors were intro-
duced via viral injection into the VTA of tyro-
sine hydroxylase (TH)::Cre transgenic rats
(Mahler et al., 2014; Witten et al., 2011),
which express the Cre enzyme only in TH-
positive neurons. As a result, the designer
receptors were selectively expressed in TH-
positive neurons of the VTA. Rats were trained
Figure 4
Hypothetical Progressive Ratio Breakpoints as a Function of Ses-
sion and Phase Using a Complex Design to Assess the Effects of
CNO Prior to and After Administration of a DREADD-
Containing Viral Vector
Note. Dose numbers indicate unspecified values of increas-
ing doses. A small effect of CNO in the absence of
DREADD expression was assumed to demonstrate the
potential benefit of the design for assessing the effect of
CNO in the absence and presence of DREADD expression
in the same animal. The dotted vertical lines indicate the
points in time at which daily breakpoint values were
deemed stable enough for probe sessions to occur. The
solid vertical line indicates the point in time when the viral
vector containing the hM3Dq receptor gene was injected.
Paul L. Soto460
to lever press using 0.2 mg/inf cocaine as a
reinforcer and subsequently underwent several
behavioral evaluations. The focus here will be
on the portion of the study that assessed the
effects of CNO administration on demand for
cocaine. During cocaine demand sessions, the
schedule of cocaine reinforcement was FR
1 and the available dose of cocaine decreased
every 10 min from 358.4 – 1.1 microg/inj (see
Bentzley et al., 2013 for detailed methods).
Hursh and Silberberg’s (2008) exponential
model of demand was fitted to consumption
of cocaine in mg in each 10 min bin as a
function of price (responses/mg) in each bin.
In hM3Dq-expressing rats, CNO dose-
dependently decreased the parameter Q0,
which represents demand at zero price
(i.e., maximal consumption), and α, which is
inversely related to reinforcer effectiveness. In
hM4Di-expressing rats, CNO dose-dependently
increased Q0 and α. In the rM3Ds-expressing
rats, CNO did not substantially alter either
parameter. CNO and vehicle were administered
and demand curves obtained in each rat, but
data were not presented to allow assessment of
reliability within or across individuals. Although
the behavioral economic demand approach
adds more complexity, because CNO is elimi-
nated from the body, its effects are suitable for
evaluation using a SCED.
A SCED approach to evaluate the effect of
hM3Dq and hM4Di receptor stimulation on
demand for cocaine could be conducted as
follows. Following cocaine self-administration
training, a demand curve for cocaine following
vehicle injection could be obtained using the
procedure of Bentzley et al. (2013) (Fig. 5,
“Before AAV - Vehicle”). Next, the effects of
CNO on cocaine demand could be evaluated
(Fig. 5, “Before AAV – CNO”). Following,
injection of the viral vector containing the
gene for the target DREADD could be admin-
istered and cocaine demand following vehicle
injection later reassessed (Fig. 5, “After AAV –
Vehicle”). Finally, CNO could be administered
presession and cocaine demand assessed
(Fig. 5, “After AAV – CNO”). Although the
effects of only a single CNO dose are shown in
Figure 5, a range of doses could be adminis-
tered to rigorously determine the effects of
neuronal stimulation and inhibition via
DREADD activation on cocaine demand.
Future Directions and Final Thoughts
This paper argues that technologies currently
available that allow initiation and termination
of biological processes in the brain permit the
application of SCED methods to the study of
the relation between such processes and behav-
ior. Application of SCED methods to study
brain–behavior relations will deepen our
understanding of the causes of behavior and
likely will lead to improved therapeutic inter-
ventions in domains involving behavior
(cf. Thompson, 2007). Such studies should be
conducted via collaborations between behavior
analysts and behavioral neuroscientists, bring-
ing together their respective areas of expertise.
In addition to the scientific value of increasing
our understanding of the causes of behavior,
there are practical benefits for behavior analysts
and behavioral neuroscientists. For behavior
analysts, the benefits include increased oppor-
tunities for interdisciplinary research efforts,
increased outlets for publication, and increased
opportunities for obtaining research funding.
For behavioral neuroscientists, the benefits
include facilitation of internal validity and
increased reproducibility of findings stemming
from the built-in replications inherent in SCED
methodology, generation of findings that apply
to individual organisms, and decreased costs
and labor stemming from a decrease in the
number of animals required.
There are a variety of directions for
investigation utilizing the technologies
Figure 5
Hypothetical Demand Curves for Cocaine from Each of Four Con-
ditions Across Which CNO Was Administered Before and After
Administration of a DREADD-Containing Viral Vector
Note. For comparison, see Figure 5A and 5B of Mahler
et al. (2019). Data points are jittered to prevent overlap.
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described in this paper that could be of inter-
est to behavioral researchers. Control over
gene transcription in a regionally, temporally,
and neuron-type specific manner allows inves-
tigation of questions such as the role of neuro-
transmitter receptors in mediating
environment–behavior relations with a preci-
sion not previously possible using gene knock-
out animals. For example, future research
could determine, in a neuron type- and
region-specific manner, which of the various
DA receptor subtypes are necessary for the
reinforcing (i.e., “abuse-related”) effects of
dopaminergic drugs such as cocaine and
amphetamine. Similar work could be done to
determine which of the various DA receptor
subtypes and what regions of their expression
contribute to the reinforcing effects of “natu-
ral” reinforcers such as food and water (see
Soto et al., 2011; Soto et al., 2016 for previous
attempts to evaluate this question in knock-
out mice).
As discussed by Thompson (2007), biologi-
cal processes and events (endogenous vari-
ables in Thompson’s terminology) may
function as motivating operations and as stim-
uli with discriminative and reinforcing conse-
quences. Control over neuronal activity in a
regionally, temporally, and neuron-type spe-
cific manner can determine the role of biolog-
ical processes and events with functions
outlined by Thompson. For example, given
the reasonable assumption that the subjective
effects of drugs arise from drug actions at
target sites in the brain, one could use
optogenetic or DREADD technologies to
probe the neurobiological systems that gener-
ate the subjective effects of drugs. Optogenetic
or DREADD-based stimulation or inhibition of
specific target neurons could be utilized in
animals trained to discriminate a drug from
vehicle to determine whether modulation of
the target neurons “substitutes” for the subjec-
tive effects of a drug (i.e., functions as a dis-
criminative stimulus for drug-appropriate
responding). Given the temporal precision of
optogenetic stimulation, one could conceivably
demonstrate control over responding on a
within-session basis at the level of individual ani-
mals (see Fig. 6). Modulation of the subjective
effects of a drug through DREADD-based stim-
ulation has been demonstrated (e.g., Jaramillo
et al., 2018), but to my knowledge, whether
such stimulation can substitute for a drug’s sub-
jective effects remains unexplored.
Another exciting possibility would be to deter-
mine whether optogenetic- or DREADD-based
modulation of targeted neuronal activity could
itself be trained as a discriminative stimulus. If
so, results such as those shown in Figure 6 might
be obtained by providing reinforcement for
responding on one alternative in the presence
of light stimulation and by providing reinforce-
ment for responding on another alternative in
the absence of light stimulation or in the pres-
ence of another light frequency (substituting
“Light On-Appropriate Responding” for “Drug-
Appropriate Responding”). The discriminative-
Figure 6
Hypothetical Proportion of Responses on a Drug-Appropriate Alternative as a Function of Time Period and the Status of an Optogenetic
Laser
Note. The graph on the left displays hypothetical data using a conventional graphing style and the graph on the right dis-
plays the data using a graphing style designed to highlight the precise temporal control that could be observed.
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stimulus effects of DREADD-based modulation
of neuronal activity could be investigated simi-
larly although on a session-by-session rather than
a within-session basis due to the duration of
action of CNO.
The possibility that optogenetic or
DREADD-based modulation of neuronal activ-
ity could function as a discriminative stimulus
appears likely based on research on fear mem-
ories. In two groundbreaking studies,
researchers demonstrated that optogenetic
stimulation of neurons can itself elicit a
response conditioned in a specific environ-
ment or be used to generate a conditioned
response to a specific environment. In the first
study, Liu et al. (2012) demonstrated that neu-
rons previously activated in a shock-paired
environment elicited freezing when those
neurons were stimulated, via optogenetics, in
a different environment. In a second study,
the same group demonstrated that an environ-
ment never paired with shock elicited freezing
if subsequent optogenetic stimulation of the
neurons that were active during initial expo-
sure to the environment was paired with shock
in a different environment (Ramirez
et al., 2013). Although discussed in terms of
memory, this research also raises fascinating
questions about the possible stimulus func-
tions of such stimulation, such as whether con-
ditioned responses would undergo extinction
with repeated stimulation and exhibit other
classical conditioning phenomena. Such
research demonstrates that stimulation of spe-
cific populations of neurons can function as
conditioned stimuli and strongly suggests that
such stimulation could exert discriminative
control over responding.
Further lines of research involve evaluating
neuronal excitation or inhibition as conse-
quences of behavior. It has long been known
that stimulation of certain populations of neu-
rons can reinforce behavior that leads to such
stimulation (Olds & Milner, 1954). Similarly,
the reinforcing consequences of optogenetic
stimulation of specific neuronal populations
have been demonstrated (e.g., Steidl &
Veverka, 2015; Stuber et al., 2011; Witten
et al., 2011). To my knowledge, the punishing
consequences of optogenetic- and DREADD-
based modulation of neuronal activity on
reinforced responding and the negative rein-
forcing effects of such stimulation remain
unexplored (although see Tan et al., 2012, for
an example of using optogenetic stimulation
to produce conditioned place aversion).
Finally, whether direct modulation of specific
neuronal populations can establish or abolish
certain events as reinforcers or punishers
(i.e., function as motivating operations) repre-
sents another interesting line of possible
research.
The technologies described here represent
opportunities for merging the rapidly advanc-
ing field of neuroscience with the methods of
behavior analysis, methods proven useful for
the analysis of the environmental determi-
nants of behavior. These technologies by no
means represent an exhaustive coverage of
those technologies utilized in behavioral neu-
roscience that could fruitfully be applied using
SCEDs. Notably, technologies offering control
with less invasiveness are being developed
(e.g., “fiberless” optogenetics; Miyazaki
et al., 2019). Behavior analysts and behavioral
neuroscientists should collaborate on efforts
to study the neurobiological determinants of
behavior in individual organisms. Collabora-
tions between behavior analysts and behavioral
neuroscientists will bring the world within the
skin under experimental control and create a
thoroughgoing analysis of the determinants of
behavior.
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